 |
Our customers say it best when describing why they choose LacriCATH®
“The success rate which I have found is greater than 95% in patients who have previously failed a routine tear duct probe... I would endorse this product without hesitation for use in congenital nasolacrimal duct obstruction.”
- Deborah R. Fishman, M.D. – Pediatric Eye Associates, Wilmette, IL
“While the cost of the product is high, the benefit to my patients has outweighed that factor. In addition, when I reviewed my data, patients would pull [tubes] out the tear duct close to 20% of the time causing inconvenience for the patient, family, and physician.”
- Robert S. Gold, M.D. – Eye Physicians of Central Florida, Longwood, FL
“It is a relatively easy surgical technique, and saves me time in the operating room compared to the nasolacrimal duct stents. It is less traumatic, and reduces the operating room and recovery time.”
- Donny W. Suh, M.D. – Wolf Eye Clinic, Marshalltown, IA
“The high success rate (>90%) along with the ease of placement and avoidance of permanent implants has benefits of avoiding securing tubes in children, and often an additional surgery to remove the tubes.”
- Lance M. Siegel, M.D. – Children’s Eye Institute, Upland, CA
“I use it mainly in the pediatric population and I would guess that my success rate is in the order of 98-99%… With the direct nasal endoscopy, the balloon catheter can be seen in its proper position within the duct.”
- Jeffrey M. Ketcham, M.D. – Fairview Red Wing Health Services, Red Wing, MN
“The benefit, of course, is that they do not have to have a silicone tube with no risk of erosion or complications from the tube.”
- Todd Watanabe, M.D. – St. Paul Eye Clinic, St. Paul, MN
“Since the invention of the LacriCATH, I rarely find it necessary to insert silastic tubes.”
- Jerry E. Berland, M.D. – Thomas Eye Group, Atlanta, GA
“The success rate certainly meets or more likely exceeds in my hands the success rate of silicone intubation and without the usual hemorrhage, tissue trauma and nuisance of tube extrusion”
- Amy Aiello Leverant, M.D. – Arizona Pediatric Eye Specialists PLC., Phoenix, AZ
“LacriCATH Saved the Day!”
- Selim T. Koseoglu, M.D. - Children’s Hospital Oakland, Oakland, CA
LacriCATH: SETTING THE STANDARD FOR QUICK, LESS INVASIVE TREATMENT OF EPIPHORA
[ News & Events Index ]
Product Orders & Information: (800) 627-0226
|
 |
